IMAX (NYSE:IMAX) Shares Gap Down - Should You Sell?

Key Points

• Shares gapped down, opening at $35.52 vs. the prior close of $38.02 and trading down roughly 5.9% on the news.
• Q1 results were mixed — the company posted an EPS beat but showed soft top‑line momentum versus tougher comparisons, while content tailwinds (e.g., Project Hail Mary) and a 10‑location Hoyts rollout in ANZ support premium revenue and international growth.
• Insiders have been net sellers (over $40M of stock in the last three months, including large individual sales), even as analysts remain mostly positive with a consensus “Moderate Buy” and an average price target of $43.70.

IMAX Corporation (NYSE:IMAX - Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $38.02, but opened at $35.52. IMAX shares last traded at $36.6190, with a volume of 319,755 shares trading hands.

More IMAX News

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX expanded its theater footprint with Hoyts, adding a 10‑location rollout across Australia and New Zealand — strengthens international capacity and box‑office runway in ANZ. IMAX & HOYTS Expand Partnership To Rollout New Cinemas Across ANZ
• Positive Sentiment: Content tailwinds: IMAX cited hits like Project Hail Mary as a meaningful Q1 box‑office contributor, showing the company can still extract premium revenue from marquee titles. Imax Hails ‘Project Hail Mary' For Q1 Boost Amid Tough Comparisons With Last Year's ‘Ne Zha 2' Bounty
• Positive Sentiment: Brand/PR wins: specialty programming (e.g., IMAX 70mm presentation of Apollo 11 in London) supports premium positioning and ancillary revenue potential. IMAX 70mm Version Of Apollo 11 Doc Now Showing At London Science Museum
• Neutral Sentiment: Q1 results were mixed: EPS beat at $0.17 (vs. $0.15 est.) and revenue slightly above estimates at $81.38M, but revenue was down ~6% YoY — a beat on the street but showing soft top‑line momentum. IMAX Corporation Reports First Quarter 2026 Results
• Neutral Sentiment: Investors can dig into the full Q1 call transcript for detail on regional trends, theatre installs and content cadence. IMAX Corporation (IMAX) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Insider sale: IMAX’s CEO sold about $333,842 of stock recently — a signal some investors interpret as a negative near‑term indicator. Insider Selling: IMAX NYSE: IMAX CEO Sells $333,842.19 in Stock
• Negative Sentiment: Press coverage emphasized that revenue and profit slipped despite big titles, reinforcing concerns over a tougher comps backdrop (last year’s Ne Zha 2) and near‑term top‑line pressure. Imax Q1 Revenue and Profit Decline Despite Hits Like ‘Avatar: Fire and Ash’ and ‘Project Hail Mary’

Analysts Set New Price Targets

A number of brokerages have recently commented on IMAX. JPMorgan Chase & Co. upped their price objective on shares of IMAX from $47.00 to $48.00 and gave the company an "overweight" rating in a research report on Thursday, February 26th. Wall Street Zen lowered shares of IMAX from a "strong-buy" rating to a "buy" rating in a research report on Saturday, February 28th. Benchmark upped their price objective on shares of IMAX from $42.00 to $44.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Seaport Research Partners upped their price objective on shares of IMAX from $43.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, April 8th. Finally, Weiss Ratings lowered shares of IMAX from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, April 24th. Nine research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, IMAX currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.70.

IMAX Stock Down 5.9%

The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 57.33, a price-to-earnings-growth ratio of 1.68 and a beta of 0.41. The company's 50-day moving average is $38.22 and its 200-day moving average is $36.42.

IMAX (NYSE:IMAX - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.15. IMAX had a net margin of 8.50% and a return on equity of 13.53%. The firm had revenue of $125.21 million during the quarter, compared to analyst estimates of $120.30 million. During the same quarter in the prior year, the business posted $0.27 earnings per share. The company's quarterly revenue was up 35.1% compared to the same quarter last year. On average, research analysts forecast that IMAX Corporation will post 1.33 earnings per share for the current year.

Insider Activity

In other news, insider Kevin Douglas sold 330,200 shares of the firm's stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $37.82, for a total transaction of $12,488,164.00. Following the completion of the sale, the insider owned 3,657,450 shares of the company's stock, valued at approximately $138,324,759. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Richard L. Gelfond sold 135,046 shares of IMAX stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $37.82, for a total transaction of $5,107,439.72. Following the completion of the transaction, the chief executive officer owned 765,002 shares of the company's stock, valued at $28,932,375.64. This trade represents a 15.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,054,284 shares of company stock valued at $40,062,532 in the last three months. Company insiders own 23.18% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. CIBC Private Wealth Group LLC acquired a new position in shares of IMAX in the 3rd quarter worth approximately $27,000. Quarry LP boosted its holdings in shares of IMAX by 166.8% in the 4th quarter. Quarry LP now owns 875 shares of the company's stock worth $32,000 after acquiring an additional 547 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of IMAX by 43.8% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company's stock worth $34,000 after acquiring an additional 317 shares in the last quarter. First Horizon Corp acquired a new position in shares of IMAX in the 3rd quarter worth approximately $34,000. Finally, Clearstead Advisors LLC acquired a new position in shares of IMAX in the 3rd quarter worth approximately $35,000. 93.51% of the stock is owned by institutional investors and hedge funds.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.